The Endocrinology, Diabetes, and Metabolism fellowship program at The Ohio State University Wexner Medical Center is an ACGME-accredited two year program designed to prepare trainees for competence in academic as well as clinical careers in Endocrinology. Through inpatient and outpatient clinical rotations, continuity clinics, research, and conferences, trainees gain experience in the pathophysiology, evaluation, and treatment of a broad spectrum of endocrine disease in adult and pediatric patients. Pediatric and reproductive endocrinology rotations are provided through arrangements with Nationwide Children’s Hospital, and the Department of Obstetrics and Gynecology. There are approximately 10,000 outpatient visits per year to the Diabetes and Endocrine Clinics. In addition to clinical training, research is a required component of the program.
Throughout the fellowship, each trainee works closely with a faculty advisor in a clinical or basic science research area of mutual interest. This relationship provides appropriate mentoring for conducting the research project and career development. A series of clinical, research, and journal club conferences organized throughout the year provides a forum for further education, interaction with faculty and visiting professors, and development of presentation skills for the fellows. Additional conferences incorporate other topics such as ethics in the practice of clinical endocrinology, compliance to appropriate billing of clinical encounters, process of applying for endocrinology positions etc. The fellowship curriculum is structured so that Board eligibility can be obtained in 24 months. A third year of fellowship is possible for those interested in pursuing additional research training for an academic career.
The division faculty is nationally and internationally recognized in various areas of endocrine research. The core faculty includes: Asem Ali, Rebecca D. Jackson, Lawrence S. Kirschner, Raheela Khawaja, Kathleen M. Dungan, Trudy Gaillard, Sheela Gokhale, Steven W. Ing, Lekshmi Nair, Matthew D. Ringel (Interim Division Director), Laura E. Ryan, Jennifer A. Sipos, Kyah Soe, Kwame Osei, and Motoyasu Saji. We also benefit from the wisdom and experience of Emeriti Professors Samuel Cataland and William B. Malarkey. Research areas available to fellows include diabetes mellitus, transplantation, gastrointestinal hormones, neuroendocrine tumors, hyperlipidemia, neuroendocrinology/neurohormones and stress, clinical and basic thyroid cancer, cell signaling, MEN syndromes, osteoporosis, primary hyperparathyroidism, and obesity disorders. Many of the faculty members hold current NIH, other federally or privately funded research grants spanning basic science to clinical outcomes research. There are opportunities to interact with collaborating scientific faculty at Ohio State as well.
The division is recognized and cited as being in the top 3 percent of all American hospitals in the specialty of endocrinology by the US News & World Report survey of America's Best Hospitals. In the 2011 report, the Endocrinology division received the highest ranking among Internal Medicine subspecialty programs at OSU. For 2011-2012, our program was ranked #27 in Diabetes & Endocrinology.